816 related articles for article (PubMed ID: 28301620)
1. Anti-Pruritic Efficacy of Itch Relief Lotion and Cream in Patients With Atopic History: Comparison With Hydrocortisone Cream.
Zirwas MJ; Barkovic S
J Drugs Dermatol; 2017 Mar; 16(3):243-247. PubMed ID: 28301620
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a Moisturizing Foam in Skin Barrier Regeneration and Itch Relief in Subjects Prone to Atopic Dermatitis.
Lio PA
J Drugs Dermatol; 2016 Nov; 15(11):s77-s80. PubMed ID: 28095568
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the moisturizing and anti-itch effects of a lactic acid and pramoxine hydrochloride cream.
Grove G; Zerweck C
Cutis; 2004 Feb; 73(2):135-9. PubMed ID: 15027519
[TBL] [Abstract][Full Text] [Related]
4. A pramoxine-based anti-itch lotion is more effective than a control lotion for the treatment of uremic pruritus in adult hemodialysis patients.
Young TA; Patel TS; Camacho F; Clark A; Freedman BI; Kaur M; Fountain J; Williams LL; Yosipovitch G; Fleischer AB
J Dermatolog Treat; 2009; 20(2):76-81. PubMed ID: 18821119
[TBL] [Abstract][Full Text] [Related]
5. Safety and Antipruritic Efficacy of a Menthol-Containing Moisturizing Cream.
Tey HL; Tay EY; Tan WD
Skinmed; 2017; 15(6):437-439. PubMed ID: 29282180
[TBL] [Abstract][Full Text] [Related]
6. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects.
Matheson R; Kempers S; Breneman D; Draelos Z; Johnson CE; Loss R; Hogan DJ; Schoenfeld R; Checketts S; Kircik L; Fivenson D; Hebert AA; Williams J; Hamlin R; Groisser D; Piacquadio D
J Drugs Dermatol; 2008 Mar; 7(3):266-71. PubMed ID: 18380208
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
[TBL] [Abstract][Full Text] [Related]
8. Steroid-free emollient formulations reduce symptoms of eczema and improve quality of life.
Weber TM; Babcock MJ; Herndon JH; Schoelermann AM; Filbry AW; Scherdin U; Neufang G; Rippke F
J Drugs Dermatol; 2014 May; 13(5):589-95. PubMed ID: 24809884
[TBL] [Abstract][Full Text] [Related]
9. A 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies.
Lisante TA; Nunez C; Zhang P; Mathes BM
J Drugs Dermatol; 2017 Jul; 16(7):671-676. PubMed ID: 28697218
[TBL] [Abstract][Full Text] [Related]
10. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
[TBL] [Abstract][Full Text] [Related]
11. Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study.
Kim BS; Sun K; Papp K; Venturanza M; Nasir A; Kuligowski ME
J Am Acad Dermatol; 2020 Jun; 82(6):1305-1313. PubMed ID: 32057960
[TBL] [Abstract][Full Text] [Related]
12. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group.
Drake LA; Millikan LE
Arch Dermatol; 1995 Dec; 131(12):1403-8. PubMed ID: 7492129
[TBL] [Abstract][Full Text] [Related]
13. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis.
Draelos ZD
J Cosmet Dermatol; 2011 Sep; 10(3):185-8. PubMed ID: 21896129
[TBL] [Abstract][Full Text] [Related]
14. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study.
Kawashima M; Tango T; Noguchi T; Inagi M; Nakagawa H; Harada S
Br J Dermatol; 2003 Jun; 148(6):1212-21. PubMed ID: 12828751
[TBL] [Abstract][Full Text] [Related]
15. Halobetasol Propionate Lotion, 0.05% Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05% in a Double-Blinded Study of Occlusivity and Hydration.
Grove G; Zerweck C; Houser T; Andrasfay A; Gauthier B; Holland C; Piacquadio D
J Drugs Dermatol; 2017 Feb; 16(2):140-144. PubMed ID: 28300856
[TBL] [Abstract][Full Text] [Related]
16. Hydrocortisone butyrate 0.1% cream (proprietary lipid rich cream vehicle) does not significantly suppress hypothalamic-pituitary-adrenal axis and is effective in pediatric patients 3 months and older with extensive atopic dermatitis.
Abramovits W; Oquendo M
Skinmed; 2010; 8(3):150-4. PubMed ID: 21137620
[TBL] [Abstract][Full Text] [Related]
17. Comparative trial of moisturizer containing licochalcone A vs. hydrocortisone lotion in the treatment of childhood atopic dermatitis: a pilot study.
Udompataikul M; Srisatwaja W
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):660-5. PubMed ID: 20840345
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled pilot study comparing aqueous cream with a beeswax and herbal oil cream in the provision of relief from postburn pruritus.
Lewis PA; Wright K; Webster A; Steer M; Rudd M; Doubrovsky A; Gardner G
J Burn Care Res; 2012; 33(4):e195-200. PubMed ID: 22665131
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and acceptability of a new topical skin lotion of sodium cromoglicate (Altoderm) in atopic dermatitis in children aged 2-12 years: a double-blind, randomized, placebo-controlled trial.
Stainer R; Matthews S; Arshad SH; McDonald S; Robinson J; Schapira C; Foote KD; Baird-Snell M; Gregory T; Pollock I; Stevens MT; Edwards AM
Br J Dermatol; 2005 Feb; 152(2):334-41. PubMed ID: 15727648
[TBL] [Abstract][Full Text] [Related]
20. Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema.
Groene D; Martus P; Heyer G
Exp Dermatol; 2001 Apr; 10(2):110-7. PubMed ID: 11260249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]